Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Operating Margin: 2010-2024

Historic Operating Margin for Ani Pharmaceuticals (ANIP) over the last 15 years, with Dec 2024 value amounting to 0.10%.

  • Ani Pharmaceuticals' Operating Margin rose 2974.00% to 15.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.70%, marking a year-over-year increase of 660.00%. This contributed to the annual value of 0.10% for FY2024, which is 955.00% down from last year.
  • Per Ani Pharmaceuticals' latest filing, its Operating Margin stood at 0.10% for FY2024, which was down 99.01% from 9.65% recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Operating Margin registered a high of 9.65% during FY2023, and its lowest value of -18.41% during FY2021.
  • In the last 3 years, Ani Pharmaceuticals' Operating Margin had a median value of 0.10% in 2024 and averaged -0.47%.
  • Its Operating Margin has fluctuated over the past 5 years, first slumped by 1,560bps in 2020, then skyrocketed by 2,080bps in 2023.
  • Ani Pharmaceuticals' Operating Margin (Yearly) stood at -7.68% in 2020, then crashed by 1,073bps to -18.41% in 2021, then spiked by 726bps to -11.15% in 2022, then soared by 2,080bps to 9.65% in 2023, then crashed by 955bps to 0.10% in 2024.